HiFSA Fingerprinting Applied to Isomers with Near-identical NMR Spectra: the Silybin/isosilybin Case
Overview
Authors
Affiliations
This study demonstrates how regio- and diastereo-isomers with near-identical NMR spectra can be distinguished and unambiguously assigned using quantum mechanical driven (1)H iterative Full Spin Analysis (HiFSA). The method is illustrated with four natural products, the flavonolignans silybin A, silybin B, isosilybin A, and isosilybin B, which exhibit extremely similar coupling patterns and chemical shift differences well below the commonly reported level of accuracy of 0.01 ppm. The HiFSA approach generated highly reproducible (1)H NMR fingerprints that enable distinction of all four isomers at (1)H frequencies from 300 to 900 MHz. Furthermore, it is demonstrated that the underlying numeric (1)H NMR profiles, combined with iterative computational analysis, allow parallel quantification of all four isomers, even in difficult to characterize reference materials and mixtures. The results shed new light on the historical challenges to the qualitative and quantitative analysis of these therapeutically relevant flavonolignans and open new opportunities to explore hidden diversity in the chemical space of organic molecules.
Geraniol-Derived Monoterpenoid Glucosides from : Resolving Structures by QM-HifSA Methodology.
Tang Y, Friesen J, Lankin D, McAlpine J, Nikolic D, Chen S J Nat Prod. 2023; 86(2):256-263.
PMID: 36744762 PMC: 10404350. DOI: 10.1021/acs.jnatprod.2c00836.
Kil Y, Nam J ACS Omega. 2022; 7(46):42607-42612.
PMID: 36440115 PMC: 9685754. DOI: 10.1021/acsomega.2c06092.
Javeed A, Ahmed M, Sajid A, Sikandar A, Aslam M, Hassan T Molecules. 2022; 27(9).
PMID: 35565993 PMC: 9102823. DOI: 10.3390/molecules27092641.
Examples Showing the Utility of Doping Experiments in H NMR Analysis of Mixtures.
Kaicharla T, Chinta B, Hoye T J Org Chem. 2022; 87(9):5660-5667.
PMID: 35442679 PMC: 9583569. DOI: 10.1021/acs.joc.1c03127.
Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.
Fallah M, Davoodvandi A, Nikmanzar S, Aghili S, Mirazimi S, Aschner M Biomed Pharmacother. 2021; 142:112024.
PMID: 34399200 PMC: 8458260. DOI: 10.1016/j.biopha.2021.112024.